Search Results for: mesoblast

Stem cell treatment cost 2.0: legit therapy

stem-money

We hear so much about exciting potential stem cell therapies, but what about stem cell treatment cost? Some of these “therapies” are rigorously evaluated ones in the FDA clinical trial pipeline and others are available right now mainly through predatory stem cell clinics. Earlier this year I posted about the cost of the offerings of […]

Stem cell treatment cost 2.0: legit therapy Read More »

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product

ViaCyte-logo-3x2

Type 1 Diabetes is a huge global problem. Where are the solutions that would compliment or replace insulin therapy for diabetics? There haven’t been too many that have gotten very far, which makes the news of a potential stem cell-based therapy moving along in the pipeline all the more exciting. ViaCyte (see more posts here,

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product Read More »

My response to ‘Our Bodies, Our Cells’ Harvard post on deregulation

Mary-Ann-Chirba

Over at the Harvard Law “Bill of Health” blog, Mary Ann Chirba and Alice A. Nobel posted a piece entitled “Our Bodies, Our Cells” a few days ago that has generated a lot of discussion about FDA regulation of stem cell interventions. Their piece really has two parts. In the first part they go through

My response to ‘Our Bodies, Our Cells’ Harvard post on deregulation Read More »

Guest blog from inside Vatican Stem Cell Meeting by John Carbona: Day 1

rome-day-1-b

The Vatican Stem Cell Meeting 2013 has started. We are fortunate to have a guest blogger, John A. Carbona, CEO of BioLife Cell Bank, who is in attendance and kindly is giving us inside coverage of the meeting. Below is a guest blog from John on Day 1 of the meeting. We even have pictures.

Guest blog from inside Vatican Stem Cell Meeting by John Carbona: Day 1 Read More »

Interview with NeoStem CEO Robin Smith Part 2: VSEL, ES cells, and iPS cells

I recently did a Q&A interview with NeoStem CEO Dr. Robin Smith. I posted Part 1 of that interview a few days ago here. Now we have part two focused on VSEL, ES cells, and iPS cells. PK: I frequently have readers of my blog ask questions about VSEL. They seem puzzled and unsure of

Interview with NeoStem CEO Robin Smith Part 2: VSEL, ES cells, and iPS cells Read More »